Article Information
History
- August 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- G Mehta1,2,4,*,
- S Lin1,3,
- A Nadar1,
- PV Bharadwaj5,
- R Kumar5,
- A Balaji5,
- S Macdonald1,4,
- M Sheikh1,4,
- MM Saeidinejad1,4,
- SR Sharma4,
- JJ King4,
- RP Mookerjee1,
- L McDonagh6,
- SA Afuwape1,4,
- K Moore1 and
- R Jalan1,7
- 1Institute for Liver and Digestive Health, University College London, London, UK
- 2Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK
- 3Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fujian, China
- 4Royal Free London NHS Foundation Trust, London, UK
- 5Cyberliver Ltd, London, UK
- 6Institute of Epidemiology and Health Care, University College London, London, UK
- 7European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain
- ↵*Corresponding author:
Gautam Mehta, gautam.mehta{at}ucl.ac.uk
Author Contributions: digital therapeutic design: GM, BPV, RK, AB, SA, KM, RJ; study concept and design: GM, KM, RJ; obtained funding: GM, KM; acquisition of data: GM, AN, SM, MS, MS, SRS, JK; analysis and interpretation of data: GM, SL, AN, LM; drafting of the manuscript GM, SL, SA, RJ; critical revision of the manuscript for important intellectual content: all authors.